Introduction Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by inflammation of the colon and rectum (1). This case study presents a 42-year-old man diagnosed with moderate to severe UC and response to treatment with Risankizumab, a monoclonal antibody targeting interleukin-23 (IL-23). Patient Demographics and Clinical
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Single-incision Laparoscopy for Gastrostomy
407 Reached2 Comments1 Likes
Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
861 Reached30 Comments15 Likes
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes